HEADER IMMUNE SYSTEM 27-FEB-06 2G75 TITLE CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG HEAVY CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: FAB M396, HEAVY CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: IGG LIGHT CHAIN; COMPND 8 CHAIN: B, D; COMPND 9 FRAGMENT: FAB M396, LIGHT CHAIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RECOMBINANT ANTIBODY FAB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HB2151; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PHAGEMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDZ1.0; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: RECOMBINANT ANTIBODY FAB; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: HB2151; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PHAGEMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PDZ1.0 KEYWDS SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE KEYWDS 2 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.PRABAKARAN,J.H.GAN,Y.FENG,Z.Y.ZHU,X.D.XIAO,X.JI,D.S.DIMITROV REVDAT 5 30-AUG-23 2G75 1 AUTHOR JRNL REVDAT 4 13-JUL-11 2G75 1 VERSN REVDAT 3 24-FEB-09 2G75 1 VERSN REVDAT 2 03-OCT-06 2G75 1 JRNL REVDAT 1 04-APR-06 2G75 0 JRNL AUTH P.PRABAKARAN,J.GAN,Y.FENG,Z.ZHU,V.CHOUDHRY,X.XIAO,X.JI, JRNL AUTH 2 D.S.DIMITROV JRNL TITL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS JRNL TITL 2 RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING JRNL TITL 3 ANTIBODY. JRNL REF J.BIOL.CHEM. V. 281 15829 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16597622 JRNL DOI 10.1074/JBC.M600697200 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 334072.450 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.9 REMARK 3 NUMBER OF REFLECTIONS : 34030 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1679 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.28 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 45.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2912 REMARK 3 BIN R VALUE (WORKING SET) : 0.3520 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.033 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6384 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 176 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.78000 REMARK 3 B22 (A**2) : -8.78000 REMARK 3 B33 (A**2) : 17.56000 REMARK 3 B12 (A**2) : 1.44000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.38 REMARK 3 LOW RESOLUTION CUTOFF (A) : 30.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.47 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.630 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.330 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.460 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 49.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G75 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000036772. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PROTEUM 300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34411 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 29.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.8 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 42.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 2DD8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% V/V GLYCEROL, 16% V/V ETHYLENE REMARK 280 GLYCOL, 20% W/V PEG 6000, AND 100 MM NACL IN 30 MM TRIS-HCL, PH REMARK 280 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.55200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 111.10400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -55.55200 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1 REMARK 465 SER A 215 REMARK 465 CYS A 216 REMARK 465 ASP A 217 REMARK 465 LYS A 218 REMARK 465 THR A 219 REMARK 465 SER A 220 REMARK 465 PRO A 221 REMARK 465 LEU A 222 REMARK 465 PHE A 223 REMARK 465 VAL A 224 REMARK 465 HIS A 225 REMARK 465 HIS A 226 REMARK 465 HIS A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 GLY A 231 REMARK 465 ASP A 232 REMARK 465 TYR A 233 REMARK 465 LYS A 234 REMARK 465 ASP A 235 REMARK 465 ASP A 236 REMARK 465 ASP A 237 REMARK 465 ASP A 238 REMARK 465 LYS A 239 REMARK 465 GLY A 240 REMARK 465 CYS B 212 REMARK 465 SER B 213 REMARK 465 GLN C 1 REMARK 465 SER C 215 REMARK 465 CYS C 216 REMARK 465 ASP C 217 REMARK 465 LYS C 218 REMARK 465 THR C 219 REMARK 465 SER C 220 REMARK 465 PRO C 221 REMARK 465 LEU C 222 REMARK 465 PHE C 223 REMARK 465 VAL C 224 REMARK 465 HIS C 225 REMARK 465 HIS C 226 REMARK 465 HIS C 227 REMARK 465 HIS C 228 REMARK 465 HIS C 229 REMARK 465 HIS C 230 REMARK 465 GLY C 231 REMARK 465 ASP C 232 REMARK 465 TYR C 233 REMARK 465 LYS C 234 REMARK 465 ASP C 235 REMARK 465 ASP C 236 REMARK 465 ASP C 237 REMARK 465 ASP C 238 REMARK 465 LYS C 239 REMARK 465 GLY C 240 REMARK 465 CYS D 212 REMARK 465 SER D 213 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 30 -127.74 54.09 REMARK 500 GLN A 64 120.33 -39.26 REMARK 500 LYS A 129 -72.54 -69.99 REMARK 500 SER A 130 172.55 150.98 REMARK 500 THR A 131 -97.12 -96.51 REMARK 500 SER A 186 -16.98 -48.42 REMARK 500 ASP B 51 -47.94 68.91 REMARK 500 SER B 52 25.38 -153.52 REMARK 500 SER B 67 135.33 -171.79 REMARK 500 ALA B 84 179.12 172.99 REMARK 500 ASP B 95A -114.30 66.66 REMARK 500 GLN B 109 139.22 -171.70 REMARK 500 PRO B 142 -179.98 -68.59 REMARK 500 LYS B 157 -66.02 -93.85 REMARK 500 PRO B 209 -9.38 -58.00 REMARK 500 SER C 16 -164.60 -78.54 REMARK 500 SER C 30 -134.42 49.45 REMARK 500 ALA C 88 -179.53 -174.43 REMARK 500 LYS C 129 -74.57 -66.59 REMARK 500 SER C 130 173.99 150.45 REMARK 500 THR C 131 -92.40 -94.44 REMARK 500 PHE C 146 138.31 -172.83 REMARK 500 SER C 173 -8.01 -55.81 REMARK 500 ASP D 51 -50.61 68.61 REMARK 500 SER D 52 19.41 -149.59 REMARK 500 SER D 67 138.94 -176.72 REMARK 500 ALA D 84 177.44 175.27 REMARK 500 ASP D 95A -112.42 67.85 REMARK 500 GLN D 109 143.12 -171.55 REMARK 500 LYS D 157 -60.46 -92.28 REMARK 500 GLU D 199 55.82 33.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AJF RELATED DB: PDB REMARK 900 STRUCTURE OF SARS CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN REMARK 900 COMPLEXED WITH ITS RECEPTOR REMARK 900 RELATED ID: 1ZA6 RELATED DB: PDB REMARK 900 THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY REMARK 900 RELATED ID: 2DD8 RELATED DB: PDB REMARK 900 STRUCTURE OF SARS CORONAVIRUS RECEPTOR-BINDING DOMAIN COMPLEXED REMARK 900 WITH CROSS-REACTIVE NEUTRALIZING ANTIBODY DBREF 2G75 A 1 240 PDB 2G75 2G75 1 240 DBREF 2G75 B 2 213 PDB 2G75 2G75 2 213 DBREF 2G75 C 1 240 PDB 2G75 2G75 1 240 DBREF 2G75 D 2 213 PDB 2G75 2G75 2 213 SEQRES 1 A 245 GLN VAL GLN LEU GLN GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 A 245 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 A 245 GLY THR PHE SER SER TYR THR ILE SER TRP VAL ARG GLN SEQRES 4 A 245 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY GLY ILE THR SEQRES 5 A 245 PRO ILE LEU GLY ILE ALA ASN TYR ALA GLN LYS PHE GLN SEQRES 6 A 245 GLY ARG VAL THR ILE THR THR ASP GLU SER THR SER THR SEQRES 7 A 245 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 A 245 ALA VAL TYR TYR CYS ALA ARG ASP THR VAL MET GLY GLY SEQRES 9 A 245 MET ASP VAL TRP GLY GLN GLY THR THR VAL THR VAL SER SEQRES 10 A 245 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 A 245 PRO SER SER LYS SER THR SER GLY GLY THR SER ALA LEU SEQRES 12 A 245 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 A 245 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 A 245 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 A 245 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 A 245 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 A 245 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS SEQRES 18 A 245 ASP LYS THR SER PRO LEU PHE VAL HIS HIS HIS HIS HIS SEQRES 19 A 245 HIS GLY ASP TYR LYS ASP ASP ASP ASP LYS GLY SEQRES 1 B 213 SER TYR GLU LEU THR GLN PRO PRO SER VAL SER VAL ALA SEQRES 2 B 213 PRO GLY LYS THR ALA ARG ILE THR CYS GLY GLY ASN ASN SEQRES 3 B 213 ILE GLY SER LYS SER VAL HIS TRP TYR GLN GLN LYS PRO SEQRES 4 B 213 GLY GLN ALA PRO VAL LEU VAL VAL TYR ASP ASP SER ASP SEQRES 5 B 213 ARG PRO SER GLY ILE PRO GLU ARG PHE SER GLY SER ASN SEQRES 6 B 213 SER GLY ASN THR ALA THR LEU THR ILE SER ARG VAL GLU SEQRES 7 B 213 ALA GLY ASP GLU ALA ASP TYR TYR CYS GLN VAL TRP ASP SEQRES 8 B 213 SER SER SER ASP TYR VAL PHE GLY THR GLY THR LYS VAL SEQRES 9 B 213 THR VAL LEU GLY GLN PRO LYS ALA ASN PRO THR VAL THR SEQRES 10 B 213 LEU PHE PRO PRO SER SER GLU GLU PHE GLN ALA ASN LYS SEQRES 11 B 213 ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR PRO GLY SEQRES 12 B 213 ALA VAL THR VAL ALA TRP LYS ALA ASP GLY SER PRO VAL SEQRES 13 B 213 LYS ALA GLY VAL GLU THR THR LYS PRO SER LYS GLN SER SEQRES 14 B 213 ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER LEU THR SEQRES 15 B 213 PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER CYS GLN SEQRES 16 B 213 VAL THR HIS GLU GLY SER THR VAL GLU LYS THR VAL ALA SEQRES 17 B 213 PRO THR GLU CYS SER SEQRES 1 C 245 GLN VAL GLN LEU GLN GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 C 245 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 C 245 GLY THR PHE SER SER TYR THR ILE SER TRP VAL ARG GLN SEQRES 4 C 245 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY GLY ILE THR SEQRES 5 C 245 PRO ILE LEU GLY ILE ALA ASN TYR ALA GLN LYS PHE GLN SEQRES 6 C 245 GLY ARG VAL THR ILE THR THR ASP GLU SER THR SER THR SEQRES 7 C 245 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 C 245 ALA VAL TYR TYR CYS ALA ARG ASP THR VAL MET GLY GLY SEQRES 9 C 245 MET ASP VAL TRP GLY GLN GLY THR THR VAL THR VAL SER SEQRES 10 C 245 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 C 245 PRO SER SER LYS SER THR SER GLY GLY THR SER ALA LEU SEQRES 12 C 245 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 C 245 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 C 245 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 C 245 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 C 245 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 C 245 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS SEQRES 18 C 245 ASP LYS THR SER PRO LEU PHE VAL HIS HIS HIS HIS HIS SEQRES 19 C 245 HIS GLY ASP TYR LYS ASP ASP ASP ASP LYS GLY SEQRES 1 D 213 SER TYR GLU LEU THR GLN PRO PRO SER VAL SER VAL ALA SEQRES 2 D 213 PRO GLY LYS THR ALA ARG ILE THR CYS GLY GLY ASN ASN SEQRES 3 D 213 ILE GLY SER LYS SER VAL HIS TRP TYR GLN GLN LYS PRO SEQRES 4 D 213 GLY GLN ALA PRO VAL LEU VAL VAL TYR ASP ASP SER ASP SEQRES 5 D 213 ARG PRO SER GLY ILE PRO GLU ARG PHE SER GLY SER ASN SEQRES 6 D 213 SER GLY ASN THR ALA THR LEU THR ILE SER ARG VAL GLU SEQRES 7 D 213 ALA GLY ASP GLU ALA ASP TYR TYR CYS GLN VAL TRP ASP SEQRES 8 D 213 SER SER SER ASP TYR VAL PHE GLY THR GLY THR LYS VAL SEQRES 9 D 213 THR VAL LEU GLY GLN PRO LYS ALA ASN PRO THR VAL THR SEQRES 10 D 213 LEU PHE PRO PRO SER SER GLU GLU PHE GLN ALA ASN LYS SEQRES 11 D 213 ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR PRO GLY SEQRES 12 D 213 ALA VAL THR VAL ALA TRP LYS ALA ASP GLY SER PRO VAL SEQRES 13 D 213 LYS ALA GLY VAL GLU THR THR LYS PRO SER LYS GLN SER SEQRES 14 D 213 ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER LEU THR SEQRES 15 D 213 PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER CYS GLN SEQRES 16 D 213 VAL THR HIS GLU GLY SER THR VAL GLU LYS THR VAL ALA SEQRES 17 D 213 PRO THR GLU CYS SER FORMUL 5 HOH *176(H2 O) HELIX 1 1 ARG A 83 THR A 87 5 5 HELIX 2 2 SER A 156 ALA A 158 5 3 HELIX 3 3 LYS A 201 ASN A 204 5 4 HELIX 4 4 GLU B 79 GLU B 83 5 5 HELIX 5 5 SER B 122 GLN B 127 1 6 HELIX 6 6 THR B 182 HIS B 189 1 8 HELIX 7 7 ARG C 83 THR C 87 5 5 HELIX 8 8 SER C 156 ALA C 158 5 3 HELIX 9 9 LYS C 201 ASN C 204 5 4 HELIX 10 10 GLU D 79 GLU D 83 5 5 HELIX 11 11 SER D 122 GLN D 127 1 6 HELIX 12 12 THR D 182 HIS D 189 1 8 SHEET 1 A 4 LEU A 4 GLN A 6 0 SHEET 2 A 4 VAL A 18 ALA A 24 -1 O LYS A 23 N GLN A 5 SHEET 3 A 4 THR A 77 LEU A 82 -1 O MET A 80 N VAL A 20 SHEET 4 A 4 VAL A 67 THR A 71 -1 N THR A 70 O TYR A 79 SHEET 1 B 6 GLU A 10 LYS A 12 0 SHEET 2 B 6 THR A 107 VAL A 111 1 O THR A 110 N LYS A 12 SHEET 3 B 6 ALA A 88 ASP A 95 -1 N TYR A 90 O THR A 107 SHEET 4 B 6 ILE A 34 GLN A 39 -1 N VAL A 37 O TYR A 91 SHEET 5 B 6 LEU A 45 ILE A 51 -1 O ILE A 51 N ILE A 34 SHEET 6 B 6 ALA A 57 TYR A 59 -1 O ASN A 58 N GLY A 50 SHEET 1 C 4 GLU A 10 LYS A 12 0 SHEET 2 C 4 THR A 107 VAL A 111 1 O THR A 110 N LYS A 12 SHEET 3 C 4 ALA A 88 ASP A 95 -1 N TYR A 90 O THR A 107 SHEET 4 C 4 MET A 100A TRP A 103 -1 O VAL A 102 N ARG A 94 SHEET 1 D 4 SER A 120 LEU A 124 0 SHEET 2 D 4 THR A 135 TYR A 145 -1 O LEU A 141 N PHE A 122 SHEET 3 D 4 TYR A 176 PRO A 185 -1 O VAL A 184 N SER A 136 SHEET 4 D 4 VAL A 163 THR A 165 -1 N HIS A 164 O VAL A 181 SHEET 1 E 4 SER A 120 LEU A 124 0 SHEET 2 E 4 THR A 135 TYR A 145 -1 O LEU A 141 N PHE A 122 SHEET 3 E 4 TYR A 176 PRO A 185 -1 O VAL A 184 N SER A 136 SHEET 4 E 4 VAL A 169 LEU A 170 -1 N VAL A 169 O SER A 177 SHEET 1 F 3 THR A 151 TRP A 154 0 SHEET 2 F 3 ILE A 195 HIS A 200 -1 O ASN A 197 N SER A 153 SHEET 3 F 3 THR A 205 LYS A 210 -1 O VAL A 207 N VAL A 198 SHEET 1 G 5 SER B 10 VAL B 13 0 SHEET 2 G 5 THR B 102 VAL B 106 1 O THR B 105 N VAL B 13 SHEET 3 G 5 ALA B 84 ASP B 92 -1 N ALA B 84 O VAL B 104 SHEET 4 G 5 VAL B 33 GLN B 38 -1 N HIS B 34 O GLN B 89 SHEET 5 G 5 VAL B 45 VAL B 48 -1 O VAL B 48 N TRP B 35 SHEET 1 H 4 SER B 10 VAL B 13 0 SHEET 2 H 4 THR B 102 VAL B 106 1 O THR B 105 N VAL B 13 SHEET 3 H 4 ALA B 84 ASP B 92 -1 N ALA B 84 O VAL B 104 SHEET 4 H 4 ASP B 95A PHE B 98 -1 O ASP B 95A N ASP B 92 SHEET 1 I 3 ALA B 19 GLY B 24 0 SHEET 2 I 3 THR B 70 ILE B 75 -1 O ALA B 71 N CYS B 23 SHEET 3 I 3 PHE B 62 SER B 67 -1 N SER B 63 O THR B 74 SHEET 1 J 4 THR B 115 PHE B 119 0 SHEET 2 J 4 ALA B 131 PHE B 140 -1 O SER B 138 N THR B 115 SHEET 3 J 4 TYR B 173 LEU B 181 -1 O ALA B 175 N ILE B 137 SHEET 4 J 4 VAL B 160 THR B 162 -1 N GLU B 161 O TYR B 178 SHEET 1 K 4 THR B 115 PHE B 119 0 SHEET 2 K 4 ALA B 131 PHE B 140 -1 O SER B 138 N THR B 115 SHEET 3 K 4 TYR B 173 LEU B 181 -1 O ALA B 175 N ILE B 137 SHEET 4 K 4 SER B 166 LYS B 167 -1 N SER B 166 O ALA B 174 SHEET 1 L 4 SER B 154 PRO B 155 0 SHEET 2 L 4 THR B 146 ALA B 151 -1 N ALA B 151 O SER B 154 SHEET 3 L 4 TYR B 192 HIS B 198 -1 O GLN B 195 N ALA B 148 SHEET 4 L 4 SER B 201 VAL B 207 -1 O VAL B 203 N VAL B 196 SHEET 1 M 4 LEU C 4 GLN C 6 0 SHEET 2 M 4 VAL C 18 ALA C 24 -1 O LYS C 23 N GLN C 5 SHEET 3 M 4 THR C 77 LEU C 82 -1 O MET C 80 N VAL C 20 SHEET 4 M 4 VAL C 67 THR C 71 -1 N THR C 70 O TYR C 79 SHEET 1 N 6 GLU C 10 LYS C 12 0 SHEET 2 N 6 THR C 107 VAL C 111 1 O THR C 110 N LYS C 12 SHEET 3 N 6 ALA C 88 ASP C 95 -1 N TYR C 90 O THR C 107 SHEET 4 N 6 ILE C 34 GLN C 39 -1 N GLN C 39 O VAL C 89 SHEET 5 N 6 GLU C 46 THR C 52 -1 O ILE C 51 N ILE C 34 SHEET 6 N 6 ILE C 56 TYR C 59 -1 O ASN C 58 N GLY C 50 SHEET 1 O 4 GLU C 10 LYS C 12 0 SHEET 2 O 4 THR C 107 VAL C 111 1 O THR C 110 N LYS C 12 SHEET 3 O 4 ALA C 88 ASP C 95 -1 N TYR C 90 O THR C 107 SHEET 4 O 4 MET C 100A TRP C 103 -1 O VAL C 102 N ARG C 94 SHEET 1 P 4 SER C 120 LEU C 124 0 SHEET 2 P 4 THR C 135 TYR C 145 -1 O LEU C 141 N PHE C 122 SHEET 3 P 4 TYR C 176 PRO C 185 -1 O VAL C 184 N SER C 136 SHEET 4 P 4 VAL C 163 THR C 165 -1 N HIS C 164 O VAL C 181 SHEET 1 Q 4 SER C 120 LEU C 124 0 SHEET 2 Q 4 THR C 135 TYR C 145 -1 O LEU C 141 N PHE C 122 SHEET 3 Q 4 TYR C 176 PRO C 185 -1 O VAL C 184 N SER C 136 SHEET 4 Q 4 VAL C 169 LEU C 170 -1 N VAL C 169 O SER C 177 SHEET 1 R 3 THR C 151 TRP C 154 0 SHEET 2 R 3 ILE C 195 HIS C 200 -1 O ASN C 197 N SER C 153 SHEET 3 R 3 THR C 205 LYS C 210 -1 O VAL C 207 N VAL C 198 SHEET 1 S 5 SER D 10 VAL D 13 0 SHEET 2 S 5 THR D 102 VAL D 106 1 O THR D 105 N VAL D 13 SHEET 3 S 5 ALA D 84 ASP D 92 -1 N ALA D 84 O VAL D 104 SHEET 4 S 5 VAL D 33 GLN D 38 -1 N TYR D 36 O TYR D 87 SHEET 5 S 5 VAL D 45 VAL D 48 -1 O VAL D 48 N TRP D 35 SHEET 1 T 4 SER D 10 VAL D 13 0 SHEET 2 T 4 THR D 102 VAL D 106 1 O THR D 105 N VAL D 13 SHEET 3 T 4 ALA D 84 ASP D 92 -1 N ALA D 84 O VAL D 104 SHEET 4 T 4 ASP D 95A PHE D 98 -1 O ASP D 95A N ASP D 92 SHEET 1 U 3 ALA D 19 GLY D 24 0 SHEET 2 U 3 THR D 70 ILE D 75 -1 O ALA D 71 N CYS D 23 SHEET 3 U 3 PHE D 62 SER D 67 -1 N SER D 63 O THR D 74 SHEET 1 V 4 THR D 115 PHE D 119 0 SHEET 2 V 4 ALA D 131 PHE D 140 -1 O SER D 138 N THR D 115 SHEET 3 V 4 TYR D 173 LEU D 181 -1 O ALA D 175 N ILE D 137 SHEET 4 V 4 VAL D 160 THR D 162 -1 N GLU D 161 O TYR D 178 SHEET 1 W 4 THR D 115 PHE D 119 0 SHEET 2 W 4 ALA D 131 PHE D 140 -1 O SER D 138 N THR D 115 SHEET 3 W 4 TYR D 173 LEU D 181 -1 O ALA D 175 N ILE D 137 SHEET 4 W 4 SER D 166 LYS D 167 -1 N SER D 166 O ALA D 174 SHEET 1 X 4 SER D 154 PRO D 155 0 SHEET 2 X 4 THR D 146 ALA D 151 -1 N ALA D 151 O SER D 154 SHEET 3 X 4 TYR D 192 HIS D 198 -1 O GLN D 195 N ALA D 148 SHEET 4 X 4 SER D 201 VAL D 207 -1 O SER D 201 N HIS D 198 SSBOND 1 CYS A 22 CYS A 92 1555 1555 2.04 SSBOND 2 CYS A 140 CYS A 196 1555 1555 2.04 SSBOND 3 CYS B 23 CYS B 88 1555 1555 2.03 SSBOND 4 CYS B 135 CYS B 194 1555 1555 2.03 SSBOND 5 CYS C 22 CYS C 92 1555 1555 2.03 SSBOND 6 CYS C 140 CYS C 196 1555 1555 2.02 SSBOND 7 CYS D 23 CYS D 88 1555 1555 2.03 SSBOND 8 CYS D 135 CYS D 194 1555 1555 2.02 CISPEP 1 PHE A 146 PRO A 147 0 -0.53 CISPEP 2 GLU A 148 PRO A 149 0 0.02 CISPEP 3 TYR B 141 PRO B 142 0 -0.44 CISPEP 4 PHE C 146 PRO C 147 0 -0.64 CISPEP 5 GLU C 148 PRO C 149 0 0.11 CISPEP 6 TYR D 141 PRO D 142 0 -1.10 CRYST1 69.066 69.066 166.656 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014479 0.008359 0.000000 0.00000 SCALE2 0.000000 0.016719 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006000 0.00000